Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-076875·Paradigm Biocapital Advisors LP
Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Ordinary Shares, par value NIS 0.01 per share · CUSIP: M96088105
Event date: 2025-08-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Paradigm BioCapital Advisors LP
Shares: 2,332,066.00 · Class: 5.0%
- Paradigm BioCapital Advisors GP LLC
Shares: 2,332,066.00 · Class: 5.0%
- Senai Asefaw, M.D.
Shares: 2,332,066.00 · Class: 5.0%
- Paradigm BioCapital International Fund Ltd.
Shares: 2,056,187.00 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-076875
- Form type
- SCHEDULE 13G
- Filer
- Paradigm Biocapital Advisors LP
- CIK
- CIK 1855655
- Filed
- Aug 12, 2025
- Reporting period
- Aug 05, 2025
- Description
- Schedule 13G beneficial ownership